Clinical Trial Update: Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial in HIV-infected adolescents evaluating regimens with or without protease inhibitors and with drug level monitoring; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Protease inhibitors (class)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED